Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Los Angeles › NPI 1952546616
Hospital

University of Southern California

University of Southern California was paid $19.48M by Medicaid between Jan 2018 and Aug 2021, across 272 billing codes. Its largest line is 0360, — 11% of everything it billed.

33Billing provider infoUNIVERSITY OF SOUTHERN CALIFORNIA
LOS ANGELES, CA 90033
33aNPI1952546616assigned 12/10/2008
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.48M
24GClaims247,869
24DCodes billed272
24AFirst – last monthJan 2018 – Aug 2021
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#126 of 410
Median peer was paid$6.90M
This provider vs. median2.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201898,503$6.17M
201977,294$6.68M
202062,610$5.62M
20219,462$1.01M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0360 11% 1,086 661 $2.15M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 6.6% 1,570 1,499 $1.28M
78815 Positron emission tomography (PET) for limited area imaging 5.9% 1,008 978 $1.16M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 5.2% 1,010 960 $1.00M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.3% 34,690 28,833 $828K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.6% 826 790 $705K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2.6% 3,256 2,368 $511K
71260 Computed tomography, thorax, diagnostic; with contrast material 2.5% 1,172 1,125 $493K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.3% 2,698 1,791 $441K
80053 Comprehensive metabolic panel 2.1% 8,483 6,936 $403K
0710 1.9% 1,312 1,239 $369K
96375 Therapeutic injection; each additional sequential IV push 1.7% 1,742 1,132 $329K
260 more codes
74178 1.7% 281 $322K
93017 1.6% 810 $309K
71250 1.6% 852 $303K
0510 1.4% 9,119 $271K
J1200 Injection, diphenhydramine hcl, up to 50 mg 1.3% 868 $262K
0272 1.2% 3,086 $236K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.1% 466 $224K
0761 1.1% 2,642 $219K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 232 $211K
A9577 Injection, gadobenate dimeglumine (multihance), per ml 1.0% 1,759 $198K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.0% 1,917 $197K
0270 <1% 3,849 $192K
0250 <1% 6,023 $190K
J0178 Injection, aflibercept, 1 mg <1% 115 $174K
86850 <1% 2,885 $174K
J3490 Unclassified drugs <1% 1,285 $171K
74183 <1% 189 $152K
93975 <1% 595 $148K
71046 Radiologic examination, chest; 2 views <1% 1,883 $141K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,859 $124K
74174 <1% 198 $124K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,487 $124K
83735 <1% 5,028 $123K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 344 $119K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 353 $117K
80197 <1% 3,566 $117K
99199 Unlisted special service, procedure or report <1% 417 $116K
J0897 Injection, denosumab, 1 mg <1% 202 $116K
Q3014 Telehealth originating site facility fee <1% 7,267 $115K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 178 $115K
86920 <1% 521 $113K
0450 Emergency room services <1% 985 $109K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 277 $101K
36415 Collection of venous blood by venipuncture <1% 9,289 $92K
92134 <1% 2,161 $91K
67028 Intravitreal injection of a pharmacologic agent <1% 574 $88K
99070 <1% 326 $87K
80048 Basic metabolic panel (calcium, ionized) <1% 1,955 $87K
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg <1% 83 $85K
J2785 Injection, regadenoson, 0.1 mg <1% 288 $85K
93325 <1% 355 $78K
86900 <1% 2,868 $77K
A0429 Emergency ambulance ride, basic life support <1% 475 $77K
82962 <1% 2,393 $76K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,830 $75K
0370 <1% 1,091 $72K
94010 <1% 811 $69K
85610 <1% 3,899 $67K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 123 $67K
J2704 Injection, propofol, 10 mg <1% 2,506 $66K
86901 <1% 3,365 $64K
96415 <1% 806 $64K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 368 $64K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 9,760 $63K
A4217 Sterile water/saline, 500 ml <1% 734 $62K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 750 $59K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 813 $57K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 310 $56K
J7050 Infusion, normal saline solution, 250 cc <1% 3,284 $55K
C9399 Unclassified drugs or biologicals <1% 112 $55K
92083 <1% 912 $55K
80069 <1% 1,344 $55K
81376 <1% 392 $51K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 173 $51K
81001 <1% 3,454 $51K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,593 $50K
87497 <1% 975 $50K
94618 <1% 253 $47K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,754 $43K
70450 Computed tomography, head or brain; without contrast material <1% 98 $43K
83036 Hemoglobin; glycosylated (A1C) <1% 3,096 $42K
72197 <1% 57 $41K
93320 <1% 125 $39K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 567 $37K
81373 <1% 432 $37K
73030 <1% 392 $36K
71045 Radiologic examination, chest; single view <1% 902 $36K
86833 <1% 745 $36K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,625 $35K
86832 <1% 745 $34K
84100 <1% 2,899 $33K
A9270 Non-covered item or service <1% 3,092 $32K
86807 <1% 623 $31K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 799 $29K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 83 $28K
P9011 Blood, split unit <1% 343 $27K
73562 <1% 351 $26K
96367 <1% 267 $26K
0760 <1% 727 $25K
81375 <1% 423 $24K
85730 <1% 2,313 $23K
73502 <1% 310 $23K
94729 <1% 176 $23K
93880 <1% 82 $23K
92133 <1% 460 $22K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 808 $21K
73630 <1% 242 $21K
92557 <1% 316 $20K
87070 <1% 492 $19K
86481 <1% 156 $19K
J7030 Infusion, normal saline solution , 1000 cc <1% 881 $19K
80061 Lipid panel <1% 1,037 $19K
87081 <1% 1,817 $19K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 190 $18K
72100 <1% 262 $18K
70551 Magnetic resonance imaging, brain; without contrast material <1% 44 $18K
94726 <1% 154 $18K
85027 <1% 3,078 $16K
83880 <1% 568 $16K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 908 $16K
84443 Thyroid stimulating hormone (TSH) <1% 1,247 $16K
73564 <1% 187 $16K
71275 Computed tomographic angiography, chest, with contrast material <1% 27 $16K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,539 $15K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 41 $14K
73560 <1% 140 $13K
86140 <1% 995 $13K
88342 <1% 88 $13K
Z7500 <1% 394 $13K
31231 <1% 150 $13K
82565 <1% 1,763 $13K
87186 <1% 306 $13K
86480 <1% 130 $13K
99214 Doctor's office visit, returning patient (more involved) <1% 452 $12K
96361 Intravenous infusion, hydration; each additional hour <1% 231 $12K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 14 $12K
84156 <1% 679 $11K
81025 <1% 684 $11K
97597 <1% 354 $11K
74230 <1% 106 $11K
87086 Culture, bacterial; quantitative colony count, urine <1% 762 $11K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,469 $11K
87205 <1% 451 $11K
0271 <1% 648 $11K
93970 <1% 43 $11K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,003 $10K
86592 <1% 293 $10K
94060 <1% 44 $9K
J1170 Injection, hydromorphone, up to 4 mg <1% 460 $9K
92504 <1% 282 $9K
87077 <1% 613 $9K
J7120 Ringers lactate infusion, up to 1000 cc <1% 186 $7K
82570 <1% 962 $7K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 257 $7K
93922 <1% 81 $7K
G0378 Hospital observation service, per hour <1% 201 $7K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 183 $7K
31575 <1% 94 $6K
J1644 Injection, heparin sodium, per 1000 units <1% 550 $6K
86317 <1% 271 $6K
72110 <1% 60 $5K
J3590 Unclassified biologics <1% 59 $5K
99213 Doctor's office visit, returning patient (routine) <1% 233 $5K
31579 <1% 25 $5K
87040 <1% 44 $5K
83970 <1% 142 $5K
J2270 Injection, morphine sulfate, up to 10 mg <1% 330 $5K
87340 <1% 244 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 100 $4K
72050 <1% 14 $4K
72141 <1% 13 $4K
84439 <1% 328 $4K
C1760 Closure device, vascular (implantable/insertable) <1% 24 $4K
83540 <1% 386 $4K
83550 <1% 371 $4K
83605 <1% 165 $4K
83690 <1% 191 $3K
86704 <1% 198 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,964 $3K
82728 <1% 236 $3K
73522 <1% 24 $3K
86803 <1% 122 $3K
83615 <1% 203 $3K
72170 <1% 40 $3K
73610 <1% 33 $3K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 75 $2K
74241 <1% 25 $2K
82550 <1% 66 $2K
87150 <1% 71 $2K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 242 $2K
82607 <1% 228 $2K
20610 <1% 120 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 349 $2K
87210 <1% 109 $2K
85651 <1% 242 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 29 $2K
87102 <1% 108 $2K
82105 <1% 161 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 471 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 43 $2K
92526 <1% 71 $2K
83037 <1% 79 $2K
93971 <1% 14 $1K
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 47 $1K
96417 <1% 72 $1K
84484 <1% 65 $1K
88304 <1% 27 $1K
86635 <1% 106 $1K
92136 <1% 27 $1K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 14 $1K
72040 <1% 19 $1K
90662 <1% 138 $1K
93926 <1% 14 $1K
86665 <1% 145 $1K
G0008 Administration of influenza virus vaccine <1% 261 $1K
0255 <1% 85 $1K
81003 <1% 212 $1K
80047 <1% 347 $1K
77080 <1% 15 $1K
76512 <1% 12 $964.56
86828 <1% 17 $963.47
82803 <1% 13 $920.34
84153 <1% 39 $879.18
92250 <1% 40 $857.52
90686 <1% 107 $740.09
92550 <1% 41 $718.66
92285 <1% 28 $712.44
86644 <1% 161 $634.52
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 22 $604.64
87116 <1% 101 $478.74
92567 <1% 32 $474.86
86645 <1% 113 $461.41
87799 <1% 34 $438.63
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 23 $414.64
80180 <1% 37 $388.79
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 60 $381.27
86235 <1% 13 $348.22
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 92 $347.37
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 17 $335.78
82330 <1% 47 $272.64
0637 <1% 192 $270.88
86431 <1% 30 $240.15
85652 <1% 159 $239.70
82947 <1% 73 $226.06
84152 <1% 14 $208.54
87015 <1% 52 $207.43
87206 <1% 83 $174.61
86160 <1% 12 $165.96
82043 <1% 61 $162.71
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 16 $161.62
69210 <1% 17 $151.55
G0009 Administration of pneumococcal vaccine <1% 13 $145.29
86039 <1% 74 $135.51
94760 <1% 14 $127.81
C1769 Guide wire <1% 15 $116.45
76514 <1% 13 $113.54
84132 <1% 64 $107.73
84550 <1% 15 $88.12
84295 <1% 47 $76.08
82435 <1% 47 $74.59
0300 <1% 292 $60.00
86849 <1% 19 $55.50
82746 <1% 12 $24.06
87275 <1% 14 $9.35
87276 <1% 14 $7.70
0260 0% 25 $0.00
G8990 Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals 0% 32 $0.00
0320 0% 16 $0.00
0636 0% 70 $0.00
G8991 Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 34 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJACKIEWICZ, THOMAS (SVP & CEO, KECK MEDICINE OF USC)
Parent organizationUNIVERSITY OF SOUTHERN CALIFOR
Same official

Other billing entities under JACKIEWICZ, THOMAS

Full network →
ProviderLocationPaid
University of Southern CaliforniaLos Angeles, CA$15.43M
University of Southern CaliforniaGlendale, CA$8.63M
University of Southern CaliforniaAlhambra, CA$2K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.